Halozyme Therapeutics
HALO
#2405
Rank
C$10.63 B
Marketcap
C$89.77
Share price
0.95%
Change (1 day)
6.85%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): C$0.65 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.39 Billion. a decrease over its 2024 earnings that were of C$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 C$0.63 B-16.2%
2024 C$0.75 B59.94%
2023 C$0.47 B39.94%
2022 C$0.33 B0.16%
2021 C$0.33 B92.2%
2020 C$0.17 B-278.96%
2019 -C$98.31 Million-9.45%
2018 -C$0.11 Billion-229.51%
2017 C$83.82 M-160.48%
2016 -C$0.14 Billion216.03%
2015 -C$43.86 Million-52.86%
2014 -C$93.04 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$72.87 Million169.94%
2011 -C$27 Million-63.44%
2010 -C$73.83 Million-7.19%
2009 -C$79.55 Million15.91%
2008 -C$68.63 Million83.89%
2007 -C$37.32 Million78.1%
2006 -C$20.96 Million16%
2005 -C$18.07 Million45.24%
2004 -C$12.44 Million682.42%
2003 -C$1.59 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.65 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$13.86 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.01 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.47 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.69 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$41.88 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA